RECORDATORIO: Nuestro equipo de la línea de atención telefónica está trabajando a distancia y centrando su tiempo en ayudar a nuestros pacientes. Agradecemos a las farmacias, a los proveedores y a su personal que utilicen nuestros Portales de Farmacia y de Proveedores. Por favor, tenga en cuenta que si se pone en contacto con nosotros sobre un pago o una subvención, es más rápido enviarnos un correo electrónico a [email protected]. Le agradecemos su paciencia y esperamos seguir sirviéndole. Les deseamos a todos seguridad y buena salud durante estos momentos difíciles. El equipo de HealthWell
Chronic Myeloid Leukemia - Medicare Access (Medicare patients only)
Status
Closed
Closed Funds
This fund is temporarily closed to new patients due to lack of sufficient funding. Please continue to visit our Disease Funds page often, as replenished funds reopen as quickly as possible. If you currently have a grant with HealthWell, your grant will remain active for the entire 12 month grant cycle or until you have exhausted your allocated grant amount, whichever comes first. You can continue to use your pharmacy card or submit requests for reimbursements during your designated grant cycle.
Fund Type
CopayPremium (Medicare Part B only)
Maximum Award Level
Pharmacy Card Fund
YesMinimum CopayReimbursement Amount
Minimum Copay Reimbursement Amount
We encourage you to please use your HealthWell pharmacy card for any applicable charges as possible.
Minimum Premium
Reimbursement Amount
Household Income Limit
500% of the Federal Poverty Level(adjusted for household size and high
cost of living areas)
Treatments Covered
- Agrylin
- Amnesteem
- Anagrelide
- Azacitidine
- Bosulif
- Bosutinib
- Busulfan
- Busulfex
- Cladribine
- Clafen
- Claravis
- Cyclophosphamide
- Cycophosphamide Intra Sol
- Cytarabine
- Cytosar-u
- Cytoxan
- Dacogen
- Dasatinib
- Daunorubicin Hydrochloride
- Decitabine
- Droxia
- Elspar
- Gleevec
- Hydrea
- Hydroxyurea
- Iclusig
- Idamycin Pfs
- Idarubicin Hcl
- Imatinib Mesylate
- Interferon Alfa-2b
- Interferon Gamma-1b
- Intron A
- Mechlorethamine Hydrochloride
- Melphalan Hydrochloride
- Mercaptopurine
- Methotrexate Lpf
- Methotrexate Sodium
- Mitoxantrone Hcl
- Mustargen
- Myleran
- Myorisan
- Nilotinib
- Omacetaxine Mepesuccinate
- Pegaspargase
- Pegasys
- Pegasys Proclick
- Pegintron Redipen
- Peglntron
- Ponatinib Hydrochloride
- Purinethol
- Roferon-a
- Scemblix
- Sotret
- Sprycel
- Synribo
- Tarabine Pfs
- Tasigna
- Vidaza
- Vincristine Sulfate
- Vindesine
Fund Definition
Assistance with the prescription drugs and biologics used in the treatment of chronic myeloid leukemia.
Grant Utilization
HealthWell estimates that patients use an average of $4,990 during their 12-month grant period for this disease area.
Do I Qualify?
HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:
-
Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Disease Funds listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.
-
This is a Medicare Access Fund. In order to qualify for premium assistance through this fund, you must have Medicare Part B. The Foundation will refer patients without Medicare to other programs, such as manufacturer patient assistance programs.
-
HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
-
If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.
About Chronic Myeloid Leukemia
Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in certain blood-forming cells of the bone marrow. In CML, a genetic change takes place in an early (immature) version of myeloid cells – the cells that make red blood cells, platelets, and most types of white blood cells (except lymphocytes). This change forms an abnormal gene called BCR-ABL, which turns the cell into a CML cell. The leukemia cells grow and divide, building up in the bone marrow and spilling over into the blood. Source: American Cancer Society
Additional Educational Resources
- CancerCare
- American Cancer Society
- American Society of Clinical Oncology
- National Cancer Institute
- National Coalition for Cancer Survivorship
- National Infusion Center Association
You may also visit our Resource List to view other copayment organizations that may provide assistance.
